| scholarly article | Q13442814 |
| P50 | author | Elizabeth V Clarke | Q59684151 |
| P2093 | author name string | Andrea J Tenner | |
| Deborah A Fraser | |||
| Pedro Morgado | |||
| Marie E Benoit | |||
| P2860 | cites work | The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation | Q24298443 |
| IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation | Q24309034 | ||
| Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells | Q24322831 | ||
| The CATERPILLER protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor alpha-, and Mycobacterium tuberculosis-induced pro-inflammatory signals | Q24337585 | ||
| Interleukin-10: new perspectives on an old cytokine | Q24653771 | ||
| C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells | Q24670661 | ||
| Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation | Q57258441 | ||
| Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP | Q68798810 | ||
| Purification and radiolabeling of human C1q | Q70831006 | ||
| Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis | Q71707145 | ||
| C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited | Q73326011 | ||
| The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells | Q73509925 | ||
| Complement receptor type 1 (CR1, CD35) is a receptor for C1q | Q73767610 | ||
| Maturation of dendritic cells abrogates C1q production in vivo and in vitro | Q75272880 | ||
| Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells | Q80475635 | ||
| Minimum information about a microarray experiment (MIAME)-toward standards for microarray data | Q27860569 | ||
| Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
| Analyzing real-time PCR data by the comparative C(T) method | Q28131831 | ||
| IL-37 is a fundamental inhibitor of innate immunity | Q28295265 | ||
| COPs and POPs: modulators of inflammasome activity | Q28387485 | ||
| Integration of biological networks and gene expression data using Cytoscape | Q28681323 | ||
| Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm | Q29614349 | ||
| How dying cells alert the immune system to danger | Q29615501 | ||
| TM4 microarray software suite | Q29618829 | ||
| Gene expression of the A- and B-chain of mouse C1q in different tissues and the characterization of the recombinant A-chain | Q33436583 | ||
| C1q enhances microglial clearance of apoptotic neurons and neuronal blebs, and modulates subsequent inflammatory cytokine production | Q33601747 | ||
| The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration | Q33685823 | ||
| C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. | Q33745559 | ||
| A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo | Q33912964 | ||
| Lipopolysaccharide-Mediated IL-10 Transcriptional Regulation Requires Sequential Induction of Type I IFNs and IL-27 in Macrophages | Q33919041 | ||
| Systemic lupus erythematosus, complement deficiency, and apoptosis | Q34082803 | ||
| The inflammatory response to cell death | Q34718276 | ||
| C1q deficiency leads to the defective suppression of IFN-alpha in response to nucleoprotein containing immune complexes | Q34729450 | ||
| The role of complement in the development of systemic lupus erythematosus | Q35698485 | ||
| Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions | Q36565247 | ||
| The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. | Q36752476 | ||
| Clearance of apoptotic cells by phagocytes | Q36850155 | ||
| Complement activation and inhibition: a delicate balance. | Q37368654 | ||
| Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum | Q39327756 | ||
| Direct demonstration and quantitation of the first complement component in human serum | Q39477585 | ||
| Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex | Q39750562 | ||
| Acquisition of chemiluminescent signals from immunoblots with a digital single-lens reflex camera | Q39902264 | ||
| Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation | Q39980543 | ||
| Complement subcomponent C1q stimulates Ig production by human B lymphocytes | Q41683610 | ||
| Biosynthesis in vitro of complement subcomponents C1q, C1s and C1̅ inhibitor by resting and stimulated human monocytes | Q41843990 | ||
| Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q. | Q41940468 | ||
| Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression | Q42719812 | ||
| Phagocytic cell molecules that bind the collagen-like region of C1q. Involvement in the C1q-mediated enhancement of phagocytosis | Q43788310 | ||
| Janus kinase 3 down-regulates lipopolysaccharide-induced IL-1 beta-converting enzyme activation by autocrine IL-10. | Q44832283 | ||
| C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. | Q45973916 | ||
| Kainic acid and decorticating lesions stimulate the synthesis of C1q protein in adult rat brain. | Q46138240 | ||
| Infiltrating dendritic cells contribute to local synthesis of C1q in murine and human lupus nephritis | Q46189746 | ||
| Murine CD93 (C1qRp) contributes to the removal of apoptotic cells in vivo but is not required for C1q-mediated enhancement of phagocytosis | Q47992020 | ||
| Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. | Q51030802 | ||
| The dissociation properties of native C1 | Q52717945 | ||
| Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies | Q57089602 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| Cytoscape | Q3699942 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | macrophage | Q184204 |
| inflammasome complex | Q412405 | ||
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 5682-5693 | |
| P577 | publication date | 2012-04-20 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Complement protein C1q directs macrophage polarization and limits inflammasome activity during the uptake of apoptotic cells | |
| P478 | volume | 188 |
| Q51714471 | A Novel Mechanism for Generating the Interferon Signature in Lupus: Opsonization of Dead Cells by Complement and IgM. |
| Q37677450 | A generalized quantitative antibody homeostasis model: antigen saturation, natural antibodies and a quantitative antibody network |
| Q47117902 | A generalized quantitative antibody homeostasis model: maintenance of global antibody equilibrium by effector functions |
| Q37260702 | A novel "complement-metabolism-inflammasome axis" as a key regulator of immune cell effector function |
| Q52886621 | Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in Macrophages. |
| Q28385358 | Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity |
| Q38131447 | Autoimmunity in 2012. |
| Q38230898 | Beyond apoptosis in lupus |
| Q37038275 | Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes |
| Q91868632 | Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages |
| Q39915125 | C1q Binding to and Uptake of Apoptotic Lymphocytes by Human Monocyte-derived Macrophages. |
| Q36555765 | C1q Modulates the Response to TLR7 Stimulation by Pristane-Primed Macrophages: Implications for Pristane-Induced Lupus |
| Q39341140 | C1q and HMGB1 reciprocally regulate human macrophage polarization |
| Q37319669 | C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice. |
| Q36414882 | C1q limits dendritic cell differentiation and activation by engaging LAIR-1 |
| Q36508752 | C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity |
| Q39364237 | C1q: A fresh look upon an old molecule |
| Q52650379 | C1r/C1s deficiency is insufficient to induce murine systemic lupus erythematosus. |
| Q41526188 | Calreticulin Release at an Early Stage of Death Modulates the Clearance by Macrophages of Apoptotic Cells |
| Q38926368 | Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis |
| Q40306336 | Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain |
| Q92185716 | Cigarette smoke-induced reduction of C1q promotes emphysema |
| Q37004951 | Complement Component C1q Programs a Pro-Efferocytic Phenotype while Limiting TNFα Production in Primary Mouse and Human Macrophages |
| Q39147404 | Complement Protein C1q Enhances Macrophage Foam Cell Survival and Efferocytosis. |
| Q28263460 | Complement System Part II: Role in Immunity |
| Q33870357 | Complement activation and regulation in preeclamptic placenta |
| Q45169996 | Complement and autoimmunity |
| Q52574294 | Complement and the Regulation of T Cell Responses. |
| Q51464431 | Complement component C1q as potential diagnostic but not predictive marker of preeclampsia. |
| Q33432423 | Complement in disease: a defence system turning offensive |
| Q38991044 | Complement in removal of the dead - balancing inflammation |
| Q34341409 | Complement modulation of T cell immune responses during homeostasis and disease. |
| Q35227723 | Complement protein C1q bound to apoptotic cells suppresses human macrophage and dendritic cell-mediated Th17 and Th1 T cell subset proliferation. |
| Q37499216 | Complement protein C1q promotes macrophage anti-inflammatory M2-like polarization during the clearance of atherogenic lipoproteins |
| Q38246272 | Complement, c1q, and c1q-related molecules regulate macrophage polarization |
| Q85959086 | Complement--tapping into new sites and effector systems |
| Q64118822 | Complementing the Cancer-Immunity Cycle |
| Q34501875 | Complementing the inflammasome. |
| Q33625486 | Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression. |
| Q92562100 | Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease |
| Q36607908 | Extracellular traps and macrophages: new roles for the versatile phagocyte. |
| Q36972852 | Fundamental role of C1q in autoimmunity and inflammation |
| Q58572607 | Human and Murine Evidence for Mechanisms Driving Autoimmune Photosensitivity |
| Q35125344 | Increased complement C1q level marks active disease in human tuberculosis. |
| Q90683704 | Inflammasomes in the pathophysiology of autoinflammatory syndromes |
| Q60303389 | Inflammasomes: Pandora's box for sepsis |
| Q47145785 | Interaction of Complement Defence Collagens C1q and Mannose-Binding Lectin with BMP-1/Tolloid-like Proteinases. |
| Q95832213 | Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer |
| Q33880198 | Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis |
| Q41633494 | Macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins are modulated by complement protein C1q. |
| Q27007951 | Macrophage proliferation, provenance, and plasticity in macroparasite infection |
| Q30573013 | Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation |
| Q92538680 | Meta-Analysis of in vitro-Differentiated Macrophages Identifies Transcriptomic Signatures That Classify Disease Macrophages in vivo |
| Q91942476 | Microglial Corpse Clearance: Lessons From Macrophages |
| Q40048102 | NLRP3 and Potassium Efflux Drive Rapid IL-1β Release from Primary Human Monocytes during Toxoplasma gondii Infection. |
| Q36553792 | Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages |
| Q47396517 | Novel mechanisms and functions of complement. |
| Q91105718 | Pancreatic cancer-educated macrophages protect cancer cells from complement-dependent cytotoxicity by up-regulation of CD59 |
| Q38148584 | Prospects of apoptotic cell-based therapies for transplantation and inflammatory diseases |
| Q90405075 | Recent advances into the role of pattern recognition receptors in transplantation |
| Q58212954 | Relative Contribution of C1q and Apoptotic Cell-Surface Calreticulin to Macrophage Phagocytosis |
| Q47199815 | Role of inflammasomes in inflammatory autoimmune rheumatic diseases |
| Q91583164 | Role of the complement system in the tumor microenvironment |
| Q92711301 | Roles of Inflammasomes in Inflammatory Kidney Diseases |
| Q60046944 | Rusty Microglia: Trainers of Innate Immunity in Alzheimer's Disease |
| Q94569843 | Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma |
| Q37531487 | Sterol Regulatory Element-Binding Protein-1c Regulates Inflammasome Activation in Gingival Fibroblasts Infected with High-Glucose-Treated Porphyromonas gingivalis. |
| Q91892624 | Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosis |
| Q49898514 | Targeting complement-mediated immunoregulation for cancer immunotherapy |
| Q55222053 | The Classical Complement Pathway Is Required to Control Borrelia burgdorferi Levels During Experimental Infection. |
| Q38315987 | The Role of Macrophages in Promoting and Maintaining Homeostasis at the Fetal-Maternal Interface. |
| Q38213193 | The complement system in systemic lupus erythematosus: an update |
| Q28649846 | The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability |
| Q34127758 | The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis? |
| Q39277496 | The many ways tissue phagocytes respond to dying cells |
| Q88535342 | The regulatory dendritic cell marker C1q is a potent inhibitor of allergic inflammation |
| Q30278701 | The role of C1q in recognition of apoptotic epithelial cells and inflammatory cytokine production by phagocytes during Helicobacter pylori infection |
| Q36914129 | The role of the immune response in age-related macular degeneration |
| Q36863273 | Therapeutic Targets for Management of Periodontitis and Diabetes |
| Q47121974 | Therapeutic Targets for Management of Periodontitis and Diabetes |
| Q38952668 | Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases |
| Q37210044 | Transcriptomic Insights into the Response of Placenta and Decidua Basalis to the CpG Oligodeoxynucleotide Stimulation in Non-Obese Diabetic Mice and Wild-Type Controls |
| Q33740754 | Trichinella spiralis Calreticulin Binds Human Complement C1q As an Immune Evasion Strategy |
| Q33690051 | Upregulation of Early and Downregulation of Terminal Pathway Complement Genes in Subcutaneous Adipose Tissue and Adipocytes in Acquired Obesity |
| Q30409296 | Viral infection of the lung: host response and sequelae |
| Q47948714 | Zebrafish earns its stripes for in vivo ASC speck dynamics |
| Q55317227 | siRNA Library Screening Identifies a Druggable Immune-Signature Driving Esophageal Adenocarcinoma Cell Growth. |
Search more.